Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated)
- Generic Name
- Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated)
- Brand Names
- Fluad Quadrivalent, Fluarix Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses. These vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which results in an immunological defense against future...
- Associated Conditions
- -
- Associated Therapies
- -
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-26
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 192
- Registration Number
- NCT06054269
- Locations
- 🇵🇪
Hospital Nacional Cayetano Heredia, Lima, Peru
🇵🇪Hospital Nacional Arzobispo Loayza, Lima, Peru
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath